Connect with us

Restoril (temazepam)

Temazepam (or RESTORIL®) is mainly prescribed to treat insomnia and other sleep disorders.

Status: ACTIVE

Class: Benzodiazepine

FDA Approval: 1981

Dosage Forms: 7.5 mg, 15 mg, 22.5 mg, 30 mg

Biological Half-life: 8-20 hours

Side Effects: Dizziness, sleepiness, ataxia, amnesia, fatigue, headache, slurred speech, lethargy, muscle weakness, numbed emotions

Serious Risks: Should NOT be taken during pregnancy

Routes of Administration: Oral

Pregnancy Category: X (US)


© 2018 Mental Daily. All Rights Reserved.
Our content is for informational purposes and should not be used as medical or treatment recommendation.